$59.83
+1.85 (+3.18%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+4.3% upside
Low Target
$43.17
Average Target
$62.39
High Target
$72.87
Current Price
$59.83
Current
$59.83
$59.83
Target
$62.39
$62.39
$43.17
$62.39 avg
$72.87
Scenario Analysis
Bear Case
$43.17
-27.8%
Low target
Base Case
$62.39
+4.3%
Avg target
Bull Case
$72.87
+21.8%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$63.60
-5.9% from high
52-Week Low
$26.76
+123.6% from low
50-Day SMA
$55.80
+7.2% vs SMA
200-Day SMA
$44.53
+34.3% vs SMA
RSI (14)
67.1
Neutral
Target vs 52W High
$62.39
-1.9% vs high
Next Earnings Report
Nov 9, 2026
1d
tomorrow
EPS Est: $0.37
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |